KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Cash & Equivalents (2016 - 2025)

Lam Research (LRCX) has 17 years of Cash & Equivalents data on record, last reported at $6.2 billion in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 9.09% year-over-year to $6.2 billion; the TTM value through Dec 2025 reached $6.2 billion, up 9.09%, while the annual FY2025 figure was $6.4 billion, 9.28% up from the prior year.
  • Cash & Equivalents reached $6.2 billion in Q4 2025 per LRCX's latest filing, down from $6.7 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $6.7 billion in Q3 2025 and bottomed at $3.5 billion in Q2 2022.
  • Average Cash & Equivalents over 5 years is $5.2 billion, with a median of $5.3 billion recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: fell 20.29% in 2022, then soared 51.53% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $5.1 billion in 2021, then decreased by 11.83% to $4.5 billion in 2022, then grew by 25.39% to $5.6 billion in 2023, then rose by 0.75% to $5.7 billion in 2024, then grew by 9.09% to $6.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $6.2 billion in Q4 2025, $6.7 billion in Q3 2025, and $6.4 billion in Q2 2025.